Senior Scientist, Process Chemistry at ORIC Pharmaceuticals | South San Francisco, California, US | Rezi

Senior Scientist, Process Chemistry at ORIC Pharmaceuticals

Senior Scientist, Process Chemistry

ORIC Pharmaceuticals · South San Francisco, California, US

1 months ago

Senior Scientist, Process Chemistry

ORIC Pharmaceuticals · South San Francisco, California, US

a month ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

ORIC Pharmaceuticals is seeking a highly motivated Process Development and Chemistry Senior Scientist to design and execute multi-step experimental studies, utilizing analytical tools to ensure safe and scalable processes. This role involves cross-functional collaboration, authoring technical reports, and facilitating technology transfer for GMP manufacturing.

Responsibilities

  • Design, planning, and execution of multi-step experimental studies to provide safe, efficient, robust and scalable processes.
  • Independently use PAT and analytical tools and interpret data to gain reaction understanding.
  • Share literature and available resources to support relevant precedent for process research.
  • Perform experiments and interpret data (calorimetry, TGA, DSC) to safely scale reactions.
  • Author development reports and technical packages, and author/review relevant sections in health authority filings (including INDs, NDAs, annual reports, and any other regulatory interactions) and patents.
  • Prepare presentation materials and clearly communicate research results to manager, and at internal/external meetings.
  • Working cross-functionally with Analytical and Formulations Development colleagues.
  • Tech transfer to CMO and scale-up of chemistry, including supporting GMP manufacture.

Requirements

  • PhD in organic chemistry with at least 3 years for Senior Scientist and with 0-2 years’ experience for a scientist of relevant hands-on pharmaceutical/biotech industry experience in the field of new drug development.
  • Proven track record for solving process chemistry problems, including identification, optimization, and characterization of robust and scalable synthetic routes.
  • Firm understanding of mechanistic organic chemistry.
  • Working understanding of analytical tools used in process development (DSC, TGA, DVS, HPLC, NMR, KF, PLM, XRPD).
  • Able to work as part of a team with strong interpersonal skills.
  • Excellent oral and written communication skills.
  • Succinct but thorough communication skills with attention to detail, analytical/critical thinking, and data organization, presentation, and inference.
  • Demonstrated passion, curiosity, and enthusiasm in pursuing ideas and solutions despite challenges.
  • Demonstrated initiative, ownership, problem identification, problem solving, and strategic thinking.
  • Experience writing research reports and detailed reaction procedures.
  • Demonstrated ability to work independently and efficiently in a collaborative, fast-paced, integrated, multidisciplinary team.
  • Consistent demonstrated high performance, above and beyond the minimum expectations and needs.
  • Scientific excellence is demonstrated by publications, presentations, and leadership/engagement in the scientific/professional community.
  • Awareness and understanding of ICH, GMP, and regulatory guidance that are important to consider in new drug development.

Skills

  • PAT
  • Calorimetry
  • TGA
  • DSC
  • DVS
  • HPLC
  • NMR
  • KF
  • PLM
  • XRPD
  • ICH
  • GMP

Location

  • South San Francisco, California
  • San Diego, California

Work Type

  • Full-time

Experience Level

  • Senior Scientist
  • Scientist

Education Level

  • PhD in organic chemistry

Salary/Compensations

  • $175,000-$200,000

About the Company

  • ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.
  • ORIC’s clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) ORIC-114, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers.
  • Beyond these two product candidates, ORIC® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms.

Equal Opportunity

  • ORIC Pharmaceuticals, Inc. is an equal opportunity employer.
  • ORIC does not discriminate based on race, color, religion, gender, sexual orientation, gender identity, age, national origin, disability status, protected veteran status, or any other legally protected characteristic.